UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 10,206	$ 5,927
Interest, accounts receivable and other receivables, net	5,581	5,788
Assets held for sale, net (Note 4)	0	6,398
Other current assets	543	2,141
Total current assets	16,330	20,254
Finance receivables, net of allowance for credit losses of $7,740 and $11,249 as of September 30, 2025 and December 31, 2024, respectively	245,396	277,760
Collateral on foreign currency forward contract	0	2,750
Marketable investments	275	580
Deferred tax assets, net	19,330	23,484
Warrant assets	7,599	4,366
Other non-current assets	432	3,041
Total assets	289,362	332,235
Current liabilities:
Accounts payable and accrued liabilities	2,874	2,810
Liabilities held for sale (Note 4)	0	1,255
Deferred income	0	1,500
Total current liabilities	2,874	5,565
Unsecured senior notes, net	31,921	31,412
Revolving credit facility	0	6,233
Other non-current liabilities	361	335
Total liabilities	35,156	43,545
Commitments and contingencies (Note 7)
Stockholders’ equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock $0.001 par value; 250,000,000 shares authorized; 12,095,979 and 12,213,599 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	12	12
Additional paid-in capital	4,417,730	4,419,991
Accumulated deficit	(4,163,536)	(4,131,313)
Total stockholders' equity	254,206	288,690
Total liabilities and stockholders' equity	$ 289,362	$ 332,235